Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study.
Matthew A WanatXin WangRutugandha ParanjpeHua ChenMichael L JohnsonMarc L FlemingSusan M AbughoshPublished in: Research and practice in thrombosis and haemostasis (2019)
Apixaban was associated with reduced stroke/systemic embolism and bleeding when compared with warfarin. No difference was seen in thrombotic or bleeding events in patients on concurrent antiarrhythmic medications.
Keyphrases
- atrial fibrillation
- catheter ablation
- oral anticoagulants
- direct oral anticoagulants
- left atrial
- left atrial appendage
- end stage renal disease
- heart failure
- newly diagnosed
- chronic kidney disease
- percutaneous coronary intervention
- ejection fraction
- venous thromboembolism
- quality improvement
- left ventricular
- rectal cancer
- patient reported
- mitral valve